Jonnalagadda Padmavathi MD is categorized under Physicians Offices in Jersey City, NJ and active since 2007.
Jonnalagadda Padmavathi MD was established in 2007, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Physicians Offices business, which does work in the B2C market, and is classified as a Physicians Offices, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Padmavathi Jonnalagadda at the company’s single location by writing to 3438 John F Kennedy Boulevard, Jersey City, New Jersey NJ 07307 or by phoning (201) 420-0366. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Jonnalagadda Padmavathi MD |
| Contact Person: | Padmavathi Jonnalagadda |
| Address: | 3438 John F Kennedy Boulevard, Jersey City, New Jersey 07307 |
| Phone Number: | (201) 420-0366 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Physicians Offices |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Jonnalagadda Padmavathi MD was started in 2007 to provide professional Physicians Offices under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Padmavathi Jonnalagadda for inquiries that concern Jonnalagadda Padmavathi MD by calling the company number (201) 420-0366, as your correspondence is most welcome. Additionally, the physical location of the single location of Jonnalagadda Padmavathi MD can be found at the coordinates 40.74971,-74.05484 as well as the street address 3438 John F Kennedy Boulevard in Jersey City, New Jersey 07307.
For its online presence, you may visit Jonnalagadda Padmavathi MD’s website at and engage with its social media outlets through on Twitter and on Facebook.